Thus, better knowledge of ALMS1 protein function in liver fibrogenesis could expand the pathways involved in NAFLD/NASH hepatic disease present also in more common metabolic diseases. This evidence concerns the gene ALMS1 and metabolic dysfunction-associated steatotic liver disease.